Collaborator: Policy Lab U.S

The purpose of the study is to evaluate whether Pure Green tablets is a better pain reliever for the treatment of mild to moderate musculoskeletal pain.
Recruitment Status: Recruiting
Study Details:
Sponsor: Pure Green
Information provided by (Responsible Party): Pure Green
Condition or Disease: Musculoskeletal Pain
Intervention/Treatment: Drug: Cannabidiol (CBD). A single dose of Cannabidiol (CBD) when patients experience musculoskeletal pain in the trial.
Phase: Phase 2
Study Type: Interventional (Clinical Trial)
Estimated Enrolment: 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Controlled-Dose Study Using A One Time Low Dose Cannabidiol Tablet For The Treatment of Mild to Moderate Musculoskeletal Pain
Estimated Study Start Date: December 7, 2019
Estimated Primary Completion Date: March 1, 2020
Estimated Study Completion Date: April 1, 2020

CBD Products

See all posts by CBD Products

Participate in CBD Research

CBD World News is part of an active community, working to enhance our understanding of the benefits of CBD. You can become an active part of that community too, by taking part in our collaborative research. We are interested in finding out who is using CBD, how it is used, and what it is used for?

Taking part in this research will help bring the good word of CBD to life and help people all over the world discover the benefits of cannabinoids.